A citation-based method for searching scientific literature

Erin Tutty, Lara Petelin, Joanne McKinley, Mary-Anne Young, Bettina Meiser, Victoria M Rasmussen, Rowan Forbes Shepherd, Paul A James, Laura E Forrest. Eur J Hum Genet 2019
Times Cited: 8







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
665
50

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore,[...]. Sci Rep 2016
95
50

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
148
37

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott. Gynecol Oncol 2017
54
37


Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Zoe Kemp, Alice Turnbull, Shawn Yost, Sheila Seal, Shazia Mahamdallie, Emma Poyastro-Pearson, Margaret Warren-Perry, Anthony Eccleston, Min-Min Tan, Soo Hwang Teo,[...]. JAMA Netw Open 2019
23
37

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
25

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
335
25

Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
Angela George, Stan Kaye, Susana Banerjee. Nat Rev Clin Oncol 2017
85
25

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
25

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016
968
25

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
717
25

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Eric Pujade-Lauraine, Jonathan A Ledermann, Frédéric Selle, Val Gebski, Richard T Penson, Amit M Oza, Jacob Korach, Tomasz Huzarski, Andrés Poveda, Sandro Pignata,[...]. Lancet Oncol 2017
673
25

Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
Belinda Rahman, Anne Lanceley, Rebecca S Kristeleit, Jonathan A Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side. J Med Genet 2019
20
25

The integration of BRCA testing into oncology clinics.
Natalie Percival, Angela George, Jennifer Gyertson, Monica Hamill, Andreia Fernandes, Emily Davies, Nazneen Rahman, Susana Banerjee. Br J Nurs 2016
31
25

Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway.
Eli Marie Grindedal, Kjersti Jørgensen, Pernilla Olsson, Berit Gravdehaug, Hilde Lurås, Ellen Schlichting, Tone Vamre, Teresia Wangensteen, Cecilie Heramb, Lovise Mæhle. Fam Cancer 2020
5
40

Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
L Baumanis, J P Evans, N Callanan, L R Susswein. J Genet Couns 2009
53
25

Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
Paul A Cohen, Cassandra B Nichols, Lyn Schofield, Steven Van Der Werf, Nicholas Pachter. Int J Gynecol Cancer 2016
18
25


Evaluating Web-based Educational Modules on Genetic Testing for Autism among Parents of Children with Autism.
Lei Xu, Alice R Richman, Linda C Mitchell, Huabin Luo, Yong-Hui Jiang, Sara Roy, Augustus E Floyd. Am J Health Behav 2018
1
100

Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: a call for dialogue.
Wendy S Rubinstein, Hongmei Jiang, Lisa Dellefave, Alfred W Rademaker. Genet Med 2009
36
12

Pathology update to the Manchester Scoring System based on testing in over 4000 families.
D Gareth Evans, Elaine F Harkness, Inga Plaskocinska, Andrew J Wallace, Tara Clancy, Emma R Woodward, Tony A Howell, Marc Tischkowitz, Fiona Lalloo. J Med Genet 2017
25
12

Hereditary breast cancer: new genetic developments, new therapeutic avenues.
Philippe M Campeau, William D Foulkes, Marc D Tischkowitz. Hum Genet 2008
185
12


The Relationship Between Burnout and Occupational Stress in Genetic Counselors.
Brittney Johnstone, Amy Kaiser, Marie C Injeyan, Karen Sappleton, David Chitayat, Derek Stephens, Cheryl Shuman. J Genet Couns 2016
17
12

Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.
Sari Lieberman, Amnon Lahad, Ariela Tomer, Carmit Cohen, Ephrat Levy-Lahad, Aviad Raz. Genet Med 2017
18
12

What can "thematic analysis" offer health and wellbeing researchers?
Virginia Braun, Victoria Clarke. Int J Qual Stud Health Well-being 2014
508
12

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
Eric Rosenthal, Kelsey Moyes, Christopher Arnell, Brent Evans, Richard J Wenstrup. Breast Cancer Res Treat 2015
26
12

Psychological distress with direct-to-consumer genetic testing: a case report of an unexpected BRCA positive test result.
Lindsay Dohany, Shanna Gustafson, Whitney Ducaine, Dana Zakalik. J Genet Couns 2012
18
12

An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.
Paboda Ratnayake, Claire E Wakefield, Bettina Meiser, Graeme Suthers, Melanie A Price, Jessica Duffy, Kathy Tucker. Fam Cancer 2011
23
12

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.
Ranjit Manchanda, Kelly Loggenberg, Saskia Sanderson, Matthew Burnell, Jane Wardle, Sue Gessler, Lucy Side, Nyala Balogun, Rakshit Desai, Ajith Kumar,[...]. J Natl Cancer Inst 2014
102
12

Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.
Kandamurugu Manickam, Adam H Buchanan, Marci L B Schwartz, Miranda L G Hallquist, Janet L Williams, Alanna Kulchak Rahm, Heather Rocha, Juliann M Savatt, Alyson E Evans, Loren M Butry,[...]. JAMA Netw Open 2018
75
12

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
P Hartge, J P Struewing, S Wacholder, L C Brody, M A Tucker. Am J Hum Genet 1999
156
12

[Principles and practice of mass screening for disease].
J M Wilson, Y G Jungner. Bol Oficina Sanit Panam 1968
417
12

High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.
Aisha S Sie, Liesbeth Spruijt, Wendy A G van Zelst-Stams, Arjen R Mensenkamp, Marjolijn J L Ligtenberg, Han G Brunner, Judith B Prins, Nicoline Hoogerbrugge. J Genet Couns 2016
20
12

Is it time to offer BRCA1 and BRCA2 testing to all Jewish women?
K A Metcalfe, A Eisen, J Lerner-Ellis, S A Narod. Curr Oncol 2015
12
12

A systematic review of factors that act as barriers to patient referral to genetic services.
Türem Delikurt, Graham R Williamson, Violetta Anastasiadou, Heather Skirton. Eur J Hum Genet 2015
73
12

Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer.
A Brédart, J L Kop, A Depauw, O Caron, S Sultan, D Leblond, A Fajac, B Buecher, M Gauthier-Villars, C Noguès,[...]. Br J Cancer 2013
15
12

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
96
12


Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30.
Kate Brunstrom, Alexandra Murray, Marion McAllister. J Genet Couns 2016
24
12

Expanded genetic screening panel for the Ashkenazi Jewish population.
Brett Baskovich, Susan Hiraki, Kinnari Upadhyay, Philip Meyer, Shai Carmi, Nir Barzilai, Ariel Darvasi, Laurie Ozelius, Inga Peter, Judy H Cho,[...]. Genet Med 2016
19
12

MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Nadine Rayes, Deborah J Bowen, Tara Coffin, Denise Nebgen, Christine Peterson, Mark F Munsell, Kathleen Gavin, Rebecca Lechner, Jamie Crase, Deborah Polinsky,[...]. BMC Cancer 2019
12
12

Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Anita Y Kinney, Karin M Butler, Marc D Schwartz, Jeanne S Mandelblatt, Kenneth M Boucher, Lisa M Pappas, Amanda Gammon, Wendy Kohlmann, Sandra L Edwards, Antoinette M Stroup,[...]. J Natl Cancer Inst 2014
73
12

Community attitudes towards a Jewish community BRCA1/2 testing program.
Nicole Cousens, Rajneesh Kaur, Bettina Meiser, Lesley Andrews. Fam Cancer 2017
4
25

My46: a Web-based tool for self-guided management of genomic test results in research and clinical settings.
Holly K Tabor, Seema M Jamal, Joon-Ho Yu, Julia M Crouch, Aditi G Shankar, Karin M Dent, Nick Anderson, Damon A Miller, Brett T Futral, Michael J Bamshad. Genet Med 2017
17
12

Genetic Counselors' Experiences and Interest in Telegenetics and Remote Counseling.
Heather A Zierhut, Ian M MacFarlane, Zahra Ahmed, Jill Davies. J Genet Couns 2018
34
12

Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.
Sari Lieberman, Ariela Tomer, Avi Ben-Chetrit, Oded Olsha, Shalom Strano, Rachel Beeri, Sivan Koka, Hila Fridman, Karen Djemal, Itzhak Glick,[...]. Genet Med 2017
26
12

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Christopher C Riedl, Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M Tea, Margaretha Rudas, Christian F Singer, Thomas H Helbich. J Clin Oncol 2015
129
12

Returning negative results to individuals in a genomic screening program: lessons learned.
Rita M Butterfield, James P Evans, Christine Rini, Kristine J Kuczynski, Margaret Waltz, R Jean Cadigan, Katrina A B Goddard, Kristin R Muessig, Gail E Henderson. Genet Med 2019
17
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.